Recombinant Interleukin 2 Regulates Levels of c-myc mRNA in a Cloned Murine T Lymphocyte

LITERATURE CITED

• ar-Rushdi, A., Nishikura K., Erikson J., Watt R., Rovera G., and Croce C. M.. 1983. Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. Science 222:390–393.
   PubMed Web of Science ®Google Scholar
• Bishop, J. M. 1983. Cellular oncogenes and retroviruses. Annu. Rev. Biochem. 52:301–354.
   PubMed Web of Science ®Google Scholar
• Campisi, J., Gray H. E., Pardee A. B., Dean M., and Sonenschein G. E.. 1984. Cell cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell 36:241–247.
   PubMed Web of Science ®Google Scholar
• Cantrell, D. A., and Smith K. A.. 1984. The interleukin-2 T-cell system: a new cell growth model. Science 224:1312–1316.
   PubMed Web of Science ®Google Scholar
• Chirgwin, J. M., Przybyla A. E., MacDonald R. J., and Ruttle W. J.. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299.
   PubMed Web of Science ®Google Scholar
• Cochran, B. H., Zullo J., Verma I. M., and Stiles C. D.. 1984. Expression of the c-fos gene and of an /os-related gene is stimulated by platelet derived growth factor. Science 226:1080–1082.
   PubMed Web of Science ®Google Scholar
• Cooper, G. M. 1982. Cellular transforming genes. Science 217:801–806.
   PubMed Web of Science ®Google Scholar
• Darzynkiewicz, Z., and Traganos F.. 1982. RNA content and chromatin structure in cycling and noncycling cell populations studied by flow cytometry, p. 103–128. In Padilla G. M. and McCarty K. S. (ed.), Genetic expression in the cell cycle. Academic Press, Inc., New York.
   Google Scholar
• Davidson, W. F., and Parish C. R.. 1975. A procedure for removing red cells and dead cells from lymphoid cell suspensions. J. Immunol. Methods 7:291–294.
   PubMedGoogle Scholar
• Einat, M., Resnitzky D., and Kimchi A.. 1985. Close link between reduction of c-myc expression by interferon and G0/G1 arrest. Nature (London) 313:597–600.
   PubMed Web of Science ®Google Scholar
• Ely, J. M., and Fitch F. W.. 1983. Alloreactive cloned T cell lines. VII. Comparison of the kinetics of IL2 release stimulated by alloantigen or Con A. J. Immunol. 131:1274–1279.
   PubMedGoogle Scholar
• Ely, J. M., Prystowsky M. B., Eisenberg L., Quintans J., Goldwasser B., Glasebrook A. L., and Fitch F. W.. 1981. Alloreactive cloned T cell lines. V. Differential kinetics of IL2, CSF, and BCSF release by a clone T amplifier cell and its variant. J. Immunol. 127:2345–2349.
   PubMedGoogle Scholar
• Fathman, C. G., and Fitch F. W. (ed.). 1982. Isolation, characterization, and utilization of T lymphocyte clones. Academic Press, Inc., New York.
   Google Scholar
• Feinberg, A. P., and Vogelstein B.. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6–13.
   PubMed Web of Science ®Google Scholar
• Fried, J. 1977. Analysis of deoxyribonucleic acid histograms from flow cytometry: estimation of the distribution of cells in S phase. J. Histochem. Cytochem. 25:942–951.
   PubMedGoogle Scholar
• Gillis, S., Ferm M. M., Ju W., and Smith K. A.. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027–2032.
   PubMed Web of Science ®Google Scholar
• Glasebrook, A. L., and Fitch F. W.. 1980. Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytotoxic T cell lines. J. Exp. Med. 151:876–895.
   PubMedGoogle Scholar
• Glisin, V., and Crkvenjaker R.. 1974. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 13:2633–2637.
   PubMed Web of Science ®Google Scholar
• Gonda, T. J., and Metcalf D.. 1984. Expression of myb, myc, and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature (London) 310:249–251.
   PubMed Web of Science ®Google Scholar
• Goyette, M., Petropoulous C. J., Shank P. R., and Fausto N.. 1984. Regulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver. Mol. Cell. Biol. 4:1493–1498.
   PubMed Web of Science ®Google Scholar
• Greenberg, M. E., and Ziff E. B.. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (London) 311:433–438.
   PubMed Web of Science ®Google Scholar
• Handschumacher, R. E., Harding M. W., Rice J., Drugge R. J., and Speicher D. W.. 1984. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226:544–547.
   PubMed Web of Science ®Google Scholar
• Hann, S. R., and Eisenman R. N.. 1984. Proteins encoded by the human c-mvc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4:2486–2497.
   PubMed Web of Science ®Google Scholar
• Keath, E. J., Kelekar A., and Cole M. D.. 1984. Transcriptional activation of the translocated c-myc oncogene in mouse plasmacytomas: similar RNA levels in tumor and proliferating normal cells. Cell 37:521–528.
   PubMedGoogle Scholar
• Kehrl, J. H., Muraguchi A., and Fauci A. S.. 1984. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I. Eur. J. Immunol. 14:115–121.
   PubMedGoogle Scholar
• Kelly, K., Cochran B. H., Stiles C. D., and Leder P.. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610.
   PubMed Web of Science ®Google Scholar
• Koretzky, G. A., Daniele R. P., and Nowell P. C.. 1982. A phorbol ester (TPA) can replace macrophages in human lymphocyte cultures stimulated with a mitogen but not with an antigen. J. Immunol. 128:1776–1780.
   PubMedGoogle Scholar
• Krönke, M., Leonard W. J., Depper J. M., Arya S. K., Wong-Staal F., Gallo R. C., Waldmann T. A., and Greene W. C.. 1984. Cyclosporin A inhibits T cell growth factor gene expression at the level of mRNA transcription. Proc. Natl. Acad. Sci. USA 81:5214–5218.
   PubMed Web of Science ®Google Scholar
• Kruijer, W., Cooper J. A., Hunter T., and Verma I. M.. 1984. Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature (London) 312:711–716.
   PubMed Web of Science ®Google Scholar
• Land, H., Parada L. F., and Weinberg R. A.. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (London) 304:596–602.
   PubMed Web of Science ®Google Scholar
• Land, H., Parada L. F., and Weinberg R. A.. 1983. Cellular oncogenes and multistep carcinogenesis. Science 222:771–778.
   PubMed Web of Science ®Google Scholar
• Lillehoj, H. S., Malek T. R., and Shevach E. M.. 1984. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens. J. Immunol. 133:244–250.
   PubMedGoogle Scholar
• Malek, T. R., Ortega G., Jakway J. P., Chan C., and Shevach E. M.. 1984. The murine IL2 receptor. II. Monoclonal anti-IL2 receptor antibodies as specific inhibitors of T cell function in vitro. J. Immunol. 133:1976–1982.
   PubMedGoogle Scholar
• Maniatis, T., Fritsch E. F., and Sam brook J.. 1982. Molecular cloning: a laboratory manual, p. 466. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Müller, R., Bravo R., Burckhardt J., and Curran T.. 1984. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature (London) 312:716–720.
   PubMed Web of Science ®Google Scholar
• Nowell, P. C, Koretzky G. A., Reed J. C., and Hannam-Harris A. C.. 1985. Interleukins and inhibitors in human lymphocyte regulation, p. 199–212. In Ford R. J. and Maizel A. L. (ed.), Mediators in cell growth and differentiation. Raven Press Publishers, New York.
   Google Scholar
• Orosz, C. G., Fidelus R. K., Roopenian D. C., Widmer M. B., Ferguson R. M., and Bach F. H.. 1982. Analysis of cloned T cell function: dissection of cloned T cell proliferative responses using cyclosporin A. J. Immunol. 129:1865–1868.
   PubMed Web of Science ®Google Scholar
• Prystowsky, M. B., Ely J. M., Beller D. I., Eisenberg L., Goldman J., Goldman M., Goldwasser E., Ihle J., Quintans J., Renold H., Vogel S. N., and Fitch F. W.. 1982. Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes. J. Immunol. 129:2337–2344.
   PubMedGoogle Scholar
• Prystowsky, M. B., Otten G., Pierce S. K., Shay J., Olshan J., and Fitch F. W.. 1985. Lymphokine production by cloned T lymphocytes p. 13–38. In Pick E. (ed.), Lymphokines, vol. 12. Academic Press, Inc., New York.
   Google Scholar
• Reed, J. C, Nowell P. C., and Hoover R. G.. 1985. Regulation of c-myc mRNA levels in normal human lymphocytes by modulators of cellular proliferation. Proc. Natl. Acad. Sci. USA 82:4221–4224.
   PubMed Web of Science ®Google Scholar
• Reitsman, P. H., Rothberg P. G., Astrin S. M., Trial J., Bar-Shavitz Z., Hall A., Teitelbaum S. L., and Kahn A. J.. 1983. Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature (London) 306:492–494.
   PubMedGoogle Scholar
• Richman, D. P. 1980. Lymphocyte cell cycle analysis by flow cytometry: evidence for a specific postmitotic phase before return to G0. J. Cell Biol. 85:459–465.
   PubMedGoogle Scholar
• Robb, R. J. 1984. Interleukin 2: the molecule and its function. Immunol. Today 5:203–206.
   PubMedGoogle Scholar
• Rosenberg, S. A., Grimm E. A., McGrogan M., Doyle M., Kawasaki E., Koths K., and Mark D. F.. 1984. Biological activity of recombinant human interleukin 2 produced in Escherichia coli. Science 223:1412–4415.
   PubMed Web of Science ®Google Scholar
• Stadler, B. M., Kristensen F., and de Weck A. L.. 1980. Thymocyte activation by cytokines: direct assessment of G0-G1 transition by flow cytometry. Cell. Immunol. 55:436–443.
   PubMedGoogle Scholar
• Steward, T. A., Bellue A. R., and Leder P.. 1984. Transcription and promoter usage of the myc gene in normal somatic and spermatogenic cells. Science 226:707–710.
   PubMedGoogle Scholar
• Taub, R., Moulding C., Battey J., Murphy W., Vasick T., Lenoir G. M., and Leder P.. 1984. Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells. Cell 36:339–348.
   PubMed Web of Science ®Google Scholar
• Thomas, P. S. 1980. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA 77:5201–5205.
   PubMed Web of Science ®Google Scholar
• Thompson, C. B., Challoner P. B., Neiman P. E., and Giroudine M.. 1985. Levels of c-myc oncogene mRNA are invariant through the cell cycle. Nature (London) 314:363–366.
   PubMed Web of Science ®Google Scholar
• Van der She, D., Janich S., Scheidereit G., Rankawitz R., Schute G., and Beato M.. 1985. Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters. Nature (London) 313:766–768.
   Google Scholar
• Wang, A., Lu S. D., and Mark D. F.. 1984. Site-specific mutagenesis of the human interleukin 2 gene: structure-function analysis of the cysteine residues. Science 224:1431–1433.
   PubMed Web of Science ®Google Scholar
• Wang, B., Heacock E., Collins I., Hutchinson K., Tilney N., and Mannick J.. 1981. Suppressive effects of cyclosporin A on the induction of alloreactivity in vitro and in vivo. J. Immunol. 127:89–93.
   PubMedGoogle Scholar